What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Pathology
His primary areas of investigation include Pathology, Adenocarcinoma, Lung cancer, Lung and Carcinoma.
The study incorporates disciplines such as Respiratory disease and Large cell in addition to Pathology.
His research in Respiratory disease intersects with topics in Interstitial lung disease, Idiopathic interstitial pneumonia, Idiopathic pulmonary fibrosis, Usual interstitial pneumonia and Anatomical pathology.
His biological study spans a wide range of topics, including KRAS, Gene and Oncology.
His studies in Lung cancer integrate themes in fields like Stage, Cancer, Metastasis and Clinical trial.
His work in Lung addresses subjects such as Radiology, which are connected to disciplines such as Surgery.
His most cited work include:
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (3017 citations)
- American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias (3012 citations)
- Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Pathology, Lung, Internal medicine, Adenocarcinoma and Lung cancer.
The concepts of his Pathology study are interwoven with issues in Respiratory disease and Interstitial lung disease.
Lung is closely attributed to Radiology in his study.
His research integrates issues of Gastroenterology, Surgery and Oncology in his study of Internal medicine.
The Adenocarcinoma study combines topics in areas such as KRAS and Cumulative incidence.
His biological study deals with issues like Cancer research, which deal with fields such as Carcinogenesis.
He most often published in these fields:
- Pathology (55.91%)
- Lung (31.82%)
- Internal medicine (25.30%)
What were the highlights of his more recent work (between 2014-2021)?
- Pathology (55.91%)
- Lung (31.82%)
- Internal medicine (25.30%)
In recent papers he was focusing on the following fields of study:
William D. Travis spends much of his time researching Pathology, Lung, Internal medicine, Adenocarcinoma and Oncology.
His study in Immunohistochemistry, Biopsy, Carcinoma, Mesothelioma and Neuroendocrine tumors are all subfields of Pathology.
His Lung research integrates issues from Pathologic stage, Cell, Radiology and Cohort.
His study looks at the relationship between Adenocarcinoma and topics such as Cumulative incidence, which overlap with Gastroenterology and Retrospective cohort study.
He combines subjects such as Survival rate, Radiation therapy and Immunotherapy with his study of Oncology.
His work carried out in the field of Lung cancer brings together such families of science as Cancer, Metastasis, Clinical trial and Disease.
Between 2014 and 2021, his most popular works were:
- The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification (1601 citations)
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. (1326 citations)
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. (910 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Pathology
William D. Travis mostly deals with Pathology, Lung cancer, Internal medicine, Adenocarcinoma and Lung.
His Lung cancer research includes themes of Cancer, Metastasis, Clinical trial and Disease.
His work deals with themes such as Surgery and Oncology, which intersect with Internal medicine.
His research integrates issues of Carcinoma, Poorly differentiated and Proportional hazards model in his study of Oncology.
His Adenocarcinoma research is multidisciplinary, relying on both Tumor microenvironment, Tissue microarray, Retrospective cohort study and FOXP3.
His Lung research integrates issues from Virus, Radiology and Pathogenesis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
